Showing results (1281-1290 of 1,365) with videos related to
Sort By:
Pageof 137
Scientific Reports|April 28, 2024
Surgical treatment improves overall survival of hepatocellular carcinoma with extrahepatic metastases after conversion therapy: a multicenter retrospective studyXiaoshi Zhang, Xiaodong Zhu, Jianhong Zhong, et al.Nature Neuroscience|May 20, 2026
Tau aggregates cause reactivation of transposable DNA elements, leading to Z-RNA-ZBP1-mediated neuronal deathWei Liu, Song-Ang Wu, Bo-Xin Zhang, et al.Journal of Medicinal Chemistry|November 19, 2019
Discovery of a Highly Selective and Potent κ Opioid Receptor Agonist from <i>N</i>-Cyclopropylmethyl-7α-phenyl-6,14-endoethanotetrahydronorthebaines with Reduced Central Nervous System (CNS) Side Effects Navigated by the Message-Address ConceptLi Xiao, Yujun Wang, Mumei Zhang, et al.Kidney International Supplements|May 13, 2021
International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Latin AmericaMarina Wainstein, Aminu K Bello, Vivekanand Jha, et al.The Lancet. Respiratory Medicine|September 12, 2024
Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trialBaohui Han, Trevor Feinstein, Yuankai Shi, et al.Gut|March 18, 2026
Token-guided multimodal prognosis in hepatocellular carcinoma: a framework steered by tumour-stroma ratioHe-Yu Huang, Kun Wu, Li-Mei Qu, et al.Plos Pathogens|May 17, 2023
Spike substitution T813S increases Sarbecovirus fusogenicity by enhancing the usage of TMPRSS2Yong Ma, Pengbin Li, Yunqi Hu, et al.BMJ Public Health|December 23, 2025
Initiatives to enhance referral patterns from primary care to specialist kidney care:a systematic review and meta-analysisAnukul Ghimire, Vinash Kumar Hariramani, Abdullah Abdulrahman, et al.European Journal of Cancer (Oxford, England : 1990)|January 18, 2024
Surufatinib plus toripalimab in patients with advanced neuroendocrine tumours and neuroendocrine carcinomas: An open-label, single-arm, multi-cohort phase II trialPanpan Zhang, Si Shi, Jianming Xu, et al.Cell|May 7, 2026
Disrupted molecular glue complex drives RAS inhibitor resistanceBen Sang, Ling Feng Ye, Zheng Fu, et al.Pageof 137